Singapore: Australia's Medical Research Commercialization Fund (MRCF) and the Uniseed Commercialization Fund have jointl...
Singapore: US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditio...
Singapore: Medical technology company iSonea launched its first asthma management smartphone app, AsthmaSense, for iPhon...
Singapore: Bionomics Limited launched a phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ...
After witnessing a turbulent year of 2009-10, the focus of Australia-based Sigma Pharmaceuticals in 2011 was restructu...
There is no reliable diagnostic blood test for ovarian cancer. The current market gold standard, CA125, is used as an ai...
Singapore: Australian National University (ANU) has granted an exclusive license to vaccine development company, BioDiem...
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...
Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...
Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...
Singapore: Viralytics Biotech and Amgen, released top line results on its oncolytic virotherapy investigational product...
Singapore: The pharmaceuticals industry in the Asia Pacific is thriving on the back of escalating population and increa...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Phylogica, a leading Australian peptide drug discovery company, is expanding its collaboration with Janssen B...
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...
